WC
AGN

Whitney & Co’s Allergan plc AGN Stock Holding History

Whitney & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,819
Closed -$2.98M – 111
2020
Q1 		$2.98M Sell
16,819
-8,839
-34% -$1.66M 0.73% 48
2019
Q4 		$4.91M Buy
25,658
+164
+0.6% +$29.6K 0.98% 46
2019
Q3 		$4.56M Buy
25,494
+1,905
+8% +$310K 0.95% 46
2019
Q2 		$3.95M Buy
23,589
+1,654
+8% +$229K 0.89% 47
2019
Q1 		$3.22M Buy
21,935
+1,995
+10% +$289K 0.73% 51
2018
Q4 		$2.76M Buy
19,940
+19,699
+8,174% +$3.23M 0.71% 49
2018
Q3 		$41K Buy
+241
New +$44.3K 0.01% 198

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Whitney & Co's AGN Position: Q2 2020 in Review

Whitney & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 16,819 shares — an estimated $2.98M sold.

Whitney & Co first reported a position in AGN in Q3 2018 and held it in 7 quarters. The position peaked at $4.91M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Whitney & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Whitney & Co sold 16,819 Allergan plc shares in Q2 2020, an estimated $2.98M.
  • Whitney & Co first reported a position in Allergan plc in Q3 2018 and held it in 7 quarters.
  • Whitney & Co's Allergan plc position peaked at $4.91M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Whitney & Co's 13F filing for Q2 2020, filed 13 Aug 2020.